Call for Abstract

International Conference on Nano Medicine and Nanoparticles , will be organized around the theme “Breakthroughs in Pharmaceutical Nanotechnology: Advancements and Challenges”

Nano Medicine 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Nano Medicine 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Nanomedicine is a branch of medicine that applies the knowledge and tools of  nanotechnology in the prevention and treatment of diseases. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism. Nanoparticles from 1-100 nm have been widely used to improve the drug accumulation, internalization and therapeutic efficacy. The physicochemical and biological properties of the nanoparticles can also be finely adjusted by tailoring their chemical properties, sizes, shapes, structures, morphologies, and surface properties. Nanomedicine is the medical application of nanotechnology. Nanotechnology has provided the possibility of delivering drugs to specific cells using nanoparticles. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials.

  • Track 1-1Nanomedicine Development and Applications
  • Track 1-2Current research in nanoparticles and nanomaterials
  • Track 1-3scientific interest in nanoparticles and nanomedicine
  • Track 1-4Properties of nanoparticles and nanomedicine
  • Track 1-5Nanomedicine for various diseases
  • Track 1-6Future Ascepts of Nanoparticles and Nanomedicine
  • Track 1-7Role in combination therapy

Nanotechnology seems to have gained a widespread interest in the recent years. Nanotechnology has considerably accelerated the growth of regenerative medicine in the past few years. Application of nanotechnology in regenerative medicine has revolutionized the designing of grafts and scaffolds which has resulted in new grafts/scaffold systems having significantly enhanced cellular and tissue regenerative properties. Since the cell–cell and cell-matrix interaction in biological systems takes place at the nanoscale level, the application of nanotechnology gives an edge in modifying the cellular function and/or matrix function in a more desired way to mimic the native tissue/organ. Nanomedicine introduces nanotechnology concepts into medicine and thus joins two large cross disciplinary fields with an unprecedented societal and economical potential arising from the natural combination of specific achievements in the respective fields.

  • Track 2-1Nanoscience and Nanotechnology
  • Track 2-2Drug Toxicity and Tumor Resistance
  • Track 2-3Safety and Efficacy Treatment
  • Track 2-4Medical Application of Nanotechnology
  • Track 2-5Antibacterial activity
  • Track 2-6Nanomedicine and COPD
  • Track 2-7Evolution of Drug Resistance

The computational studies in nanoparticles have demonstrated that there has been considerable progress in nano- and biotechnology in the last several years. However, several key challenges have also become apparent, including the need for a better understanding of nanoparticle behaviour in vivo and the development of more effective nanoparticle therapeutics. Computational efforts are becoming an important tool in addressing both of these challenges, as well as in generally facilitating and accelerating nanotechnology-based translational research. The nanoinformatics has comes out as a new research area that covers raw data management, analysis of the data derived from biomedical applications and simulation of nanoparticle interactions with biological systems depicting the integration of biology, nanotechnology and informatics to form the basis for computational nanomedicine.

  • Track 3-1Computational Quantum Chemistry
  • Track 3-2Quantum dots
  • Track 3-3Nanoparticles in pharmacokinetics model
  • Track 3-4Imaging and nanoparticles
  • Track 3-5Nanoparticles and thermodynamic computations
  • Track 3-6Nanoparticles in mathematical modelling
  • Track 3-7Molecular binding properties
  • Track 3-8Optical absorption
  • Track 3-9Innovative Developments of Nanoparticles
  • Track 3-10Modelling of Enzyme Inhibition
  • Track 3-11Multiple challenges of Nanoparticles
  • Track 3-12Modelling of Cellular Toxicity
  • Track 3-13Chemoinformatics
  • Track 3-14Biological Nanoparticles

Nanotechnology is a rapidly growing field having potential applications in many areas. Nanoparticles have been studied for cell toxicity, immunotoxicity, and genotoxicity. Tetrazolium-based assays such as MTT, MTS, and WST-1 are used to determine cell viability. Different types of cell cultures, including cancer cell lines have been employed as in vitro toxicity models. Considering the potential applications of NPs in many fields and the growing apprehensions of FDA about the toxic potential of nanoproducts, it is the need of the hour to look for new internationally agreed free of bias toxicological models by focusing more on in vivo studies. The rapid expansion of nanotechnology promises to have great benefits for society, yet there is increasing concern that human and environmental exposure to engineered nanomaterials may result in significant adverse effects. The system was developed for nanotoxicity assessment at single and multiple cell levels which can measure and compare the microscopic and macroscopic effects of nanoparticles interaction with cells, without interference from neighbouring cells' cues and also overall integrative effects produced by nanoparticles and cell–cell communication.

  • Track 4-1Analytical Toxicology of Nanoparticles
  • Track 4-2Oral toxicity
  • Track 4-3Toxicity to human lymphocytes
  • Track 4-4Cytotoxicity
  • Track 4-5Mitochondrial injuries
  • Track 4-6Neonatal toxicity
  • Track 4-7Challenges of toxicity
  • Track 4-8Drug Targeting
  • Track 4-9The Historical perspective in Toxicology of Nanoparticles
  • Track 4-10Nanomaterials of Different substances and their Toxicity
  • Track 4-11Complications with Nanotoxicity Studies
  • Track 4-12Immunogenicity of Nanoparticles
  • Track 4-13Toxicity due to inhalation of nanoparticles

Currently, the treatment of HIV requires regular oral dosing of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies. Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.In a four-year study conducted on the mouse model in advanced breast cancer metastasis in the eye's anterior chamber, the new nanoparticle not only killed tumour cells in the eye, but also extended the survival of experimental mice bearing 4T1 tumors, a cell line that is extremely difficult to kill. "Previous monotherapies have not extended the lifetimes of mice bearing this type of tumour".

  • Track 5-1Graphene Medicine
  • Track 5-2Image-guided drug delivery
  • Track 5-3Nanomedicine for Diabetes
  • Track 5-4Nanomedicine for Cancer
  • Track 5-5NanoMedicine for HIV
  • Track 5-6Parkinson Disease
  • Track 5-7Role in vaccines
  • Track 5-8Autoimmune diseases
  • Track 5-9Atherosclerosis

Some smart drug delivery platform is based on neutral phospholipid nanoliposomes. Classic liposomes modalities have had manufacturing problems involving sizing, uniformity, loading, storage, and enhancement compatibility, which can be overcome by employing true nanotechnology to build liposomes upon discrete self-assembling DNA scaffolds. The smart drug delivery system is used for delivering drugs to the host. Biological  information detected by biological sensors is analyzed and the drug delivery system is actuated to deliver the drug based on the information. MEMS or NEMS technology based drug pumps, micro-pumps, micro-needles, micro-osmotic pumps, and nano-pumps are utilized for smarter drug delivery. One of the concerns these days about self-assembling nanotechnology is that it is so advanced beyond the current drug paradigm that it becomes problematic from a regulatory point of view. While there is currently no drug treatment delivered directly into these types of cancers. 

  • Track 6-1Hypervariability and Adaptability for Modern Smart Drug Medicine
  • Track 6-2Cardiovascular diseases
  • Track 6-3Breast cancer treatment
  • Track 6-4Wound healing
  • Track 6-5Concepts of Synthetic Virology
  • Track 6-6Viral Gene Therapy Clinical trials
  • Track 6-7Modern Techniques Used to Develop Drugs
  • Track 6-8The Smart Drug Delivery Conundrum
  • Track 6-9MEMS technology
  • Track 6-10Role of nanoparticle mediated drug delivery in metastasis

Recent years have witnessed the rapid development of inorganic nanomaterials for medical applications. At present, nanomedicines-nanoparticles (NPs) destined for therapy or diagnosis purposes-can be found in a number of medical applications, including therapeutics and diagnosis agents. Pushing the limits of nanotechnology towards enhanced nanomedicines will surely help to reduce side effects of traditional treatments and to achieve earlier diagnosis. The interplay between engineered nanomaterials and biological components is influenced by complex interactions which make predicting their biological fate and performance a nontrivial issue. We hope that both early-stage and experienced researchers will find it valuable for designing nanoparticles for enhanced bio-performance. Nanoemulsions have attracted great attention in research, dosage form design and pharmacotherapy. This is as a result of a number of attributes peculiar to nanoemulsions.

  • Track 7-1Frontiers in Drug Design and Discovery
  • Track 7-2Enhanced Nanomedicines
  • Track 7-3SNEDDS
  • Track 7-4Engineered Nanomaterials and Biological Components
  • Track 7-5Nano-Bio Interactions
  • Track 7-6Current State of Nanoemulsions in Drug Delivery

With the remarkable development of nanotechnology in recent years, new drug delivery approaches based on the state-of-the-art nanotechnology have been receiving significant attention. Nanoparticles, an evolvement of nanotechnology, are increasingly considered as a potential candidate to carry therapeutic agents safely into a targeted compartment in an organ, particular tissue or cell. These particles are colloidal structures with a diameter less than 1,000 nm, and therefore can penetrate through diminutive capillaries into the cell’s internal machinery. This innovative delivery technique might be a promising technology to meet the current challenges in drug delivery. The different types of nanoparticles drug delivery systems under investigation and their prospective therapeutic applications, and also, presents a closer look at the advances, current challenges, and future direction of nanoparticles drug delivery systems.

  • Track 8-1New Drug Delivery Approaches
  • Track 8-2Advance combinations of Nanoparticles
  • Track 8-3 Current Challenges in Drug Delivery
  • Track 8-4Nano-Tubes in Medicine and Health Care
  • Track 8-5Significance in Neurological Disorder
  • Track 8-6Application of Nanoparticles in Pulmonary Diseases

The use of nanoscale materials and processes to address human disease is perhaps the most promising, considering that most complex downstream symptoms of disease are initiated by molecular level phenomena. Nanomedicine is defined as biological and medical intervention at the nanometer scale for the treatment, diagnosis, and increased understanding of biology and disease. Tremendous advances in the area of polymer synthesis and self-assembly have given rise to a new toolbox of engineered nanosized delivery and diagnostic agents that permit systemic and local administration, circulation in the bloodstream, and uptake and diffusion at the cellular and subcellular level.

  • Track 9-1Prepation of polymer Nanomedicine
  • Track 9-2Design of polymer Nanomedicine
  • Track 9-3Optimal characterization of polymer Nanoparticles
  • Track 9-4Development of Nanomedicine
  • Track 9-5Regulatory and clinical Development
  • Track 9-6Nanomedicine for Different clinical Applications
  • Track 9-7Future Challenges of Nanomedicine
  • Track 9-8Advances in designing of polymeric nanoparticle
  • Track 9-9Polymer nanomedicine in anti-cancer therapy

Nano Medicine Industry and Market Analysis focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and the rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. The study The Global Nanomedicine Market is poised to grow at a CAGR of around 16.6% over the next decade to reach approximately $1.3 trillion by 2025.This industry report analyses the global markets for Nanomedicine across all the given segments on global as well as regional levels presented in the research scope.

  • Track 10-1Focus on Nanopharmaceuticals
  • Track 10-2Nanotechnology tools in Pharmaceutical Research and Development
  • Track 10-3Bio Pharmaceutical Industry
  • Track 10-4An Up and Coming Market for Nanotechnology
  • Track 10-5 Industrial Applications of Nano medicine
  • Track 10-6Surface coating strategies

Nanomedicine has been developing rapidly in recent years, particularly in the development of novel nano tools for medical diagnosis and treatment. For instance, a new trend is becoming prevalent in developing nanosystems for simultaneous tumour diagnosis and therapy. A new terminology "theranostics" has been frequently used and applied in pre-clinical research and trials. A nanosystem can simultaneously achieve both cell targeted during in vivo imaging and photothermal treatment of cancer. While achieving concurrent high spatial and temporal resolution of the lesions via cell targeting; special non-evasive treatments are implemented at the same time by various means, such as localized drug release, hyperthermia, and photo-thermal therapy. Inspired by these challenging problems in biomedical fields, the development of the nanotechnologies will be the key in addressing some of the critical issues in medicine, especially in early cancer diagnosis and treatment.

  • Track 11-1Nanotechnology in Nanomedicine
  • Track 11-2Biological and Medical Research
  • Track 11-3Explicit and Revolutionary of Nanomedicine
  • Track 11-4Development and Application of Ever-Improving Nanotools
  • Track 11-5Evolutionary of Nanomedicine

The term “nano” became tantamount to “cutting-edge” and was quickly embraced by the pharmaceutical science community. The novel concept of nanomedicine generated as a result of a scientific amalgamation between nanoscience and nanotechnology with medicine. Pharmaceutical scientists quickly adopted nanoscience terminology, thus “creating” “nanopharmaceuticals”. Moreover, just using the term “nano” intuitively implied state-of-the-art research and became very fashionable within the pharmaceutical science community. Formulation of nanopharmaceuticals contain active extracts obtained from medicinal plants. In physiological conditions, the interactions between blood platelets and endothelial cells play a major role in vascular reactivity and hemostasis. In contrast, increased platelet activation contributes to the pathogenesis of vascular pathology such as atherosclerosis, thrombosis, diabetes mellitus, hypertension and carcinogenesis. The rapid developments in nanostructured materials and nanotechnology will have profound impact in many areas of biomedical applications including delivery of drugs and biomolecules, tissue engineering, detection of biomarkers, cancer diagnosis, cancer therapy, and imaging.

  • Track 12-1pharmaceutical Innovation
  • Track 12-2current Trends in nanopharmacy
  • Track 12-3Nanostructures for Medicine and Pharmaceuticals
  • Track 12-4Nanopharmacology in platelet Research
  • Track 12-5 Formulation of Nanopharmaceuticals
  • Track 12-6Nanotechnology in Pharmaceutical¬†Aerosols

Particle–particle interactions in physiological media are important determinants for nanoparticle fate and transport. Herein, such interactions are assessed by a novel atomic force microscopy -based platform. Industry-relevant CeO2, Fe2O3, and SiO2 nanoparticles of various diameters were made by the flame spray pyrolysis (FSP)-based Harvard Versatile Engineering Nanomaterials Generation System (Harvard VENGES). The nanoparticles were fully characterized both structurally and morphologically, and their properties in water and biological media were also assessed. The nanoparticles were attached on AFM tips and deposited on Si substrates to measure particle–particle interactions. Nanoparticle interactions in solution affect their binding to biomolecules, their electronic properties, and their packing into larger crystals. However, the theories that describe larger colloidal particles fail for nanoparticles, because the interactions do not add together linearly. Nanoparticle interactions are often described by classical colloidal theories developed for µPs.

  • Track 13-1The Fundamental Classification of Interactions
  • Track 13-2The CHARMM Force Field for Atomistic Interactions
  • Track 13-3Miscellaneous Interactions
  • Track 13-4The DLVO Theory of Colloidal Interactions
  • Track 13-5Entropic Interactions
  • Track 13-6Develop the patient-pharma Relationship in Nanomedicine
  • Track 13-7Solvent Effects

As the science and technology of nanomedicine speeds ahead, ethics, policy, and the law struggle to catch up also chases after it. It is important to proactively address the ethical, social and regulatory aspects of nanomedicine to minimize its adverse impacts on the environment and public health and to avoid a public backlash. In the next 10–15 years, nanotechnology is likely to revolutionize the practice of medicine and have a significant impact on human health. Nanotechnology is already contributing to the development of new drugs, biologics, and medical devices and the augmentation of existing therapeutics. Over 200 companies are involved in nanomedicine research and development. The U.S. Food and Drug Administration has approved nine different types of therapies that employ nanoscale materials, including products used for medical testing and imaging, drug delivery, wound healing, and bone and tissue repair. Discoveries and innovations in nanomedicine have occurred at a breathtaking pace in just a short time, uses of nanotechnology in medicine have moved from laboratory testing, to clinical trials, to medical applications.

  • Track 14-1Ethical Issues in Clinical Trials Involving Nanomedicine
  • Track 14-2Ethical Aspects of Nanomedicine on a short, middle, and long term perspective
  • Track 14-3Ethical Aspects of Nanotechnology in Medicine
  • Track 14-4Ethics in Medical Applications

Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect. Formulation studies also consider such factors as particle size, polymorphism, pH, and solubility, as all of these can influence bioavailability and hence the activity of a drug. The drug must be combined with inactive ingredients by a method which ensures that the quantity of drug present is consistent in each dosage unit e.g. each tablet. The dosage should have a uniform appearance, with an acceptable taste, tablet hardness, or capsule disintegration. By the time phase III clinical trials are reached, the formulation of the drug should have been developed to be close to the preparation that will ultimately be used in the market. 

  • Track 15-1Formulation and preformulation
  • Track 15-2Quality of Formulation
  • Track 15-3Formulation types
  • Track 15-4Formulation types
  • Track 15-5Formulation from plant sources

Pharmacy is the science and technique of preparing and dispensing drugs. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. A theory relating chemical structure to pharmaceutical activity emerged from the interplay of experimental results from animal and human tests using vaccines, antitoxins, and antibodies with chemical knowledge about dyes and their molecular structures. Although pharmacology is essential to the study of pharmacy, it is not specific to pharmacy. Pharmacoinformatics is as considered another new discipline, for systematic drug discovery and development with efficiency and safety. The progressively more important role of the chemist and chemical science in pharmaceuticals in the early-20th century is mirrored in the history of the American Chemical Society's Division of Medicinal Chemistry.

  • Track 16-1Pharmaceutics & Biopharmaceutics
  • Track 16-2Drug Regulatory Affairs
  • Track 16-3Pharmaceutical chemistry
  • Track 16-4Pharmacognosy & Ethnobotany
  • Track 16-5Pharmaceutical Biotechnology and Microbiology
  • Track 16-6Pharmacy practice and Hospital Pharmacy
  • Track 16-7Novel and Targeted Drug Delivery
  • Track 16-8Biomarkers